Steffen Rex1, Carlo Missant, Patrick Segers, Rolf Rossaint, Patrick F Wouters. 1. Section Centre for Experimental Anesthesiology, Emergency and Intensive Care Medicine, Department of Acute Medical Sciences, Katholieke Universiteit Leuven, Minderbroederstraat 19 - bus 7003, 3000 Leuven, Belgium.
Abstract
OBJECTIVE: Prostacyclins have been suggested to exert positive inotropic effects which would render them particularly suitable for the treatment of right ventricular (RV) dysfunction due to acute pulmonary hypertension (PHT). Data on this subject are controversial, however, and vary with the experimental conditions. We studied the inotropic effects of epoprostenol at clinically recommended doses in an experimental model of acute PHT. DESIGN AND SETTING: Prospective laboratory investigation in a university hospital laboratory. SUBJECTS: Six pigs (36 +/- 7kg). INTERVENTIONS: Pigs were instrumented with biventricular conductance catheters, a pulmonary artery (PA) flow probe, and a high-fidelity pulmonary pressure catheter. Incremental doses of epoprostenol (10, 15, 20, 30, 40ng kg(-1) min(-1)) were administered in undiseased animals and after induction of acute hypoxia-induced PHT. MEASUREMENTS AND RESULTS: In acute PHT epoprostenol markedly reduced RV afterload (slopes of pressure-flow relationship in the PA from 7.0 +/- 0.6 to 4.2 +/- 0.7mmHg minl(-1)). This was associated with a paradoxical and dose-dependent decrease in RV contractility (slope of preload-recruitable stroke-work relationship from 3.0 +/- 0.4 to 1.6 +/- 0.2 mW s ml(-1); slope of endsystolic pressure-volume relationship from 1.5 +/- 0.3 to 0.7 +/- 0.3mmHg ml(-1)). Left ventricular contractility was reduced only at the highest dose. In undiseased animals epoprostenol did not affect vascular tone and produced a mild biventricular decrease in contractility. CONCLUSIONS: Epoprostenol has no positive inotropic effects in vivo. In contrast, epoprostenol-induced pulmonary vasodilation in animals with acute PHT was associated with a paradoxical decrease in RV contractility. This effect is probably caused indirectly by the close coupling of RV contractility to RV afterload. However, data from normal animals suggest that mechanisms unrelated to vasodilation are also involved in the observed negative inotropic response to epoprostenol.
OBJECTIVE:Prostacyclins have been suggested to exert positive inotropic effects which would render them particularly suitable for the treatment of right ventricular (RV) dysfunction due to acute pulmonary hypertension (PHT). Data on this subject are controversial, however, and vary with the experimental conditions. We studied the inotropic effects of epoprostenol at clinically recommended doses in an experimental model of acute PHT. DESIGN AND SETTING: Prospective laboratory investigation in a university hospital laboratory. SUBJECTS: Six pigs (36 +/- 7kg). INTERVENTIONS:Pigs were instrumented with biventricular conductance catheters, a pulmonary artery (PA) flow probe, and a high-fidelity pulmonary pressure catheter. Incremental doses of epoprostenol (10, 15, 20, 30, 40ng kg(-1) min(-1)) were administered in undiseased animals and after induction of acute hypoxia-induced PHT. MEASUREMENTS AND RESULTS: In acute PHT epoprostenol markedly reduced RV afterload (slopes of pressure-flow relationship in the PA from 7.0 +/- 0.6 to 4.2 +/- 0.7mmHg minl(-1)). This was associated with a paradoxical and dose-dependent decrease in RV contractility (slope of preload-recruitable stroke-work relationship from 3.0 +/- 0.4 to 1.6 +/- 0.2 mW s ml(-1); slope of endsystolic pressure-volume relationship from 1.5 +/- 0.3 to 0.7 +/- 0.3mmHg ml(-1)). Left ventricular contractility was reduced only at the highest dose. In undiseased animals epoprostenol did not affect vascular tone and produced a mild biventricular decrease in contractility. CONCLUSIONS:Epoprostenol has no positive inotropic effects in vivo. In contrast, epoprostenol-induced pulmonary vasodilation in animals with acute PHT was associated with a paradoxical decrease in RV contractility. This effect is probably caused indirectly by the close coupling of RV contractility to RV afterload. However, data from normal animals suggest that mechanisms unrelated to vasodilation are also involved in the observed negative inotropic response to epoprostenol.
Authors: Boudewijn P J Leeuwenburgh; Paul Steendijk; Willem A Helbing; Jan Baan Journal: Am J Physiol Heart Circ Physiol Date: 2002-04 Impact factor: 4.733
Authors: Horst Olschewski; Frank Rose; Ralph Schermuly; H Ardeschir Ghofrani; Beate Enke; Andrea Olschewski; Werner Seeger Journal: Pharmacol Ther Date: 2004-05 Impact factor: 12.310
Authors: André P Lourenço; Francisco Vasques-Nóvoa; José Oliveira-Pinto; Dulce Fontoura; Roberto Roncon-Albuquerque; Adelino F Leite-Moreira Journal: Intensive Care Med Date: 2012-02-14 Impact factor: 17.440
Authors: Rebecca R Vanderpool; Ankit A Desai; Shannon M Knapp; Marc A Simon; Aiden Abidov; Jason X-J Yuan; Joe G N Garcia; Lillian M Hansen; Steven R Knoper; Robert Naeije; Franz P Rischard Journal: Eur Respir J Date: 2017-08-24 Impact factor: 16.671
Authors: Michael Winterhalter; Steffen Rex; Christian Stoppe; Peter Kienbaum; Hans-Helge Müller; Ines Kaufmann; Hermann Kuppe; Aristidis Dongas; Bernhard Zwissler Journal: Can J Anaesth Date: 2019-02-12 Impact factor: 5.063
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2009-01-06 Impact factor: 17.440